tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
IO Biotech Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsIO Biotech Reports Q2 2025 Financial Results
1M ago
IO Biotech’s Cylembio Shows Promise Despite Missed Endpoint, Buy Rating Affirmed
Premium
Ratings
IO Biotech’s Cylembio Shows Promise Despite Missed Endpoint, Buy Rating Affirmed
2M ago
Promising Phase 3 Results and Strategic FDA Engagement Bolster Buy Rating for IO Biotech
Premium
Ratings
Promising Phase 3 Results and Strategic FDA Engagement Bolster Buy Rating for IO Biotech
2M ago
IO Biotech Amends CEO Service Agreement
PremiumCompany AnnouncementsIO Biotech Amends CEO Service Agreement
3M ago
IO Biotech Elects New Director at Annual Meeting
Premium
Company Announcements
IO Biotech Elects New Director at Annual Meeting
4M ago
IO Biotech Regains Nasdaq Compliance with Stock Price
Premium
Company Announcements
IO Biotech Regains Nasdaq Compliance with Stock Price
4M ago
IO Biotech price target raised to $14 from $12 at H.C. Wainwright
PremiumThe FlyIO Biotech price target raised to $14 from $12 at H.C. Wainwright
5M ago
IO Biotech reports Q1 EPS (34c) vs (30c) last year
Premium
The Fly
IO Biotech reports Q1 EPS (34c) vs (30c) last year
5M ago
Positive Outlook for IO Biotech: Buy Rating Backed by Strong Cash Position and Promising Pipeline
Premium
Ratings
Positive Outlook for IO Biotech: Buy Rating Backed by Strong Cash Position and Promising Pipeline
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100